Kymera Therapeutics, Inc. <KYMR.O>: Citigroup raises target price to $135 from $120
KYMR•Related News
BKV Q2 FY26 net income falls 29.68% to $75.8 million; adjusted EBITDAX climbs 47.15% to $142 million
BKV•
Commerce Q2 FY26 swings to GAAP net income of $1.1 million; revenue rises 0.1% to $84.5 million vs year-ago quarter
CMRC•
Immunocore Q2 FY26 net loss narrows to $0.8 million; revenue rises 18% to $115.9 million
IMCR•
PENN Entertainment Q2 revenue meets estimates on retail segment strength
PENN•
Climb Bio Q2 FY26 net loss widens 55.73% to $13.5 million
CLYM•